Cáncer de mama triple negativo: otra enfermedad y nuevo reto

Contreras Castillo, Ana Cecilia.
Rev. venez. oncol ; 33(1): 46-59, mar. 2021. tab
Artigo em Espanhol | LIVECS, LILACS | ID: biblio-1147479

Documentos relacionados

  1. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
  2. [Guidelines for clinical diagnosis and treatment of advanced triple negative breast cancer in China（2024 edition）].
  3. Evaluating anthracycline + taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study.
  4. Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria.
  5. A clinical calculator to predict disease outcomes in women with triple-negative breast cancer.
  6. Gene expression in triple-negative breast cancer in relation to survival.
  7. The influence of comorbidity on treatment and survival of triple-negative breast cancer.
  8. National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial.
  9. Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.
  10. [Triple Negative Breast Cancer].